These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4. Lang S; Mary-Krause M; Cotte L; Gilquin J; Partisani M; Simon A; Boccara F; Costagliola D; Arch Intern Med; 2010 Jul; 170(14):1228-38. PubMed ID: 20660842 [TBL] [Abstract][Full Text] [Related]
9. Abacavir and increased risk of myocardial infarction. Post FA; Campbell LJ Lancet; 2008 Sep; 372(9641):803; author reply 804-5. PubMed ID: 18774412 [No Abstract] [Full Text] [Related]
10. Abacavir and cardiovascular risk: reviewing the evidence. Costagliola D; Lang S; Mary-Krause M; Boccara F Curr HIV/AIDS Rep; 2010 Aug; 7(3):127-33. PubMed ID: 20521126 [TBL] [Abstract][Full Text] [Related]
14. FDA notifications. Ongoing safety review of abacavir, possible MI risk. AIDS Alert; 2011 May; 26(5):58-9. PubMed ID: 21649950 [No Abstract] [Full Text] [Related]
15. Abacavir and cardiovascular disease: A critical look at the data. Llibre JM; Hill A Antiviral Res; 2016 Aug; 132():116-21. PubMed ID: 27260856 [TBL] [Abstract][Full Text] [Related]
16. [Current data on antiretroviral therapy. CROI 2009: tenofovir DR convinces by high effectiveness and tolerance]. Walter M MMW Fortschr Med; 2009 Apr; 151(18):76-9. PubMed ID: 19769084 [No Abstract] [Full Text] [Related]
17. Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data. Cruciani M; Zanichelli V; Serpelloni G; Bosco O; Malena M; Mazzi R; Mengoli C; Parisi SG; Moyle G AIDS; 2011 Oct; 25(16):1993-2004. PubMed ID: 21716077 [TBL] [Abstract][Full Text] [Related]
18. FDA notifications. Large study suggests heart attack risk from use of abacavir or didanosine. AIDS Alert; 2008 May; 23(5):58-9. PubMed ID: 18642404 [No Abstract] [Full Text] [Related]
19. Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV-1-infected patients treated with abacavir. Kowalska JD; Kirk O; Mocroft A; Høj L; Friis-Møller N; Reiss P; Weller I; Lundgren JD HIV Med; 2010 Mar; 11(3):200-8. PubMed ID: 19863618 [TBL] [Abstract][Full Text] [Related]